DHR Dec 2024 310.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:30AM EDT. Market open.
| Previous close | 2.4000 |
| Open | 2.4000 |
| Bid | 1.4500 |
| Ask | 2.6500 |
| Strike | 310.00 |
| Expiry date | 2024-12-20 |
| Day's range | 2.4000 - 2.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.61k |
PR NewswireBeckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term partnership to include a global distribution agreement of Scopio's Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. Scopio's X100 / X100HT with FF-BMA Application are CE-Marked.
PR NewswireDanaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on October 25, 2024 to holders of record on September 27, 2024.
ZacksHere's Why It is Appropriate to Retain Danaher Stock For Now
DHR benefits from solid momentum across its Diagnostics segment. However, increasing expenses remain a concern.
© 2024 Yahoo. All rights reserved.